Compare Oatly Group AB - ADR (OTLY) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oatly Group AB - ADR vs State Street SPDR S&P Biotech ETF — how do they compare? Oatly Group AB - ADR trades at $10.54 (market cap $282.27M), while State Street SPDR S&P Biotech ETF trades at $151.96. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Oatly Group AB - ADR nearer its low. Which is the better fit depends on your goals.
| OTLY | XBI | |
|---|---|---|
Market Cap | $282.27M | — |
Sector | Consumer Staples | Broad Market / Factor |
52-Week High | $18.54 | $164.28 |
52-Week Low | $8.03 | $85.16 |
Enterprise Value | $779.89M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oatly Group AB - ADR
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, Icecreams, among others. It caters to Sweden, Germany, United Kingdom, Netherlands, North America, Finland, and other markets.
Read more on OTLY →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
